Omniome

BiotechnologySeries CSan Diego, USomniome.com

Latest round

Series C

Last raised

Nov 2019

Total raised

$100M

Investors

9

About Omniome

Founded in 2013 and based in California, US, Omniome, Inc. is a biotechnology company that develops DNA sequencing technologies for cancer diagnostics. The company was founded by Kandaswamy Vijayan. In 2019, Omniome, Inc. In July 2021, Pacific Biosciences of California, Inc. signed a definitive agreement to acquire Omniome, Inc. The company offers a DNA sequencing technology for cancer diagnostics that delivers accurate sequencing. It also operates Sequencing By Binding (SBB) technology, a solution that enhances the precision of nucleotide and DNA matching. The company's revenue is generated by the sales of its DNA sequencing solution to its target market for industries engaged in clinical sequencing. The acquisition of Pacific Biosciences of California, Inc. by Omniome, Inc. will help in the expansion of its technology to a wider market range.

Who invested in Omniome

9 investors across 3 rounds

See all investors in Omniome

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Nov 27, 2019

    Amount

    $60M

    Investors

    Locked

  2. Series B

    Jun 28, 2018

    Amount

    $40M

    Investors

    Locked

  3. Seed

    Jun 30, 2016

    Amount

    Undisclosed

    Investors

    Locked

Questions about Omniome

Who invested in Omniome?

Omniome has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Omniome raised?

Omniome has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Omniome last raise money?

Omniome's most recent round on record is a Series C, in Nov 2019.

What does Omniome do?

Founded in 2013 and based in California, US, Omniome, Inc.

Where is Omniome headquartered?

Omniome is headquartered in San Diego, US.

Which VCs invest in companies like Omniome?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Omniome's stage. Their profiles are linked below.

Raising like Omniome? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.